Indication

Antibody Titer

1 clinical trial

1 product

Clinical trial

Randomized, Blind, Phase III Clinical Trial to Evaluate the Immunogenicity and Safety of Freeze-dried Human Rabies Vaccine (Vero Cell) Inoculated in 4-dose Program (2-1-1)

Status: Completed, Estimated PCD: 2021-10-31

Product